For the year ending 2025-12-31, AKTX has $47,892K in assets. $19,564K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 5,203 | |||
| Restricted cash | 60 | |||
| Prepaid expenses | 185 | |||
| Other current assets | 14 | |||
| Total current assets | 5,462 | |||
| Goodwill | 8,430 | |||
| Other intangible assets | 34,000 | |||
| Total assets | 47,892 | |||
| Accounts payable | 8,770 | |||
| Accrued expenses | 2,342 | |||
| Convertible notes, net | 673 | |||
| Notes payable, net | 81 | |||
| Warrant liabilities | 61 | |||
| Other current liabilities | 424 | |||
| Total current liabilities | 12,351 | |||
| Derivative liability | 230 | |||
| Other non-current liabilities | 31 | |||
| Deferred tax liability | 6,952 | |||
| Total liabilities | 19,564 | |||
| Additional paid-in capital | 234,318 | |||
| Capital redemption reserve | 59,342 | |||
| Accumulated other comprehensive loss | -782 | |||
| Accumulated deficit | -264,550 | |||
| Total shareholders equity | 28,328 | |||
| Total liabilities and shareholders equity | 47,892 | |||
Akari Therapeutics Plc (AKTX)
Akari Therapeutics Plc (AKTX)